Market PotentialHeartflow is poised to deliver above-average growth and margin performance, with a projected 24% growth CAGR in the 2025-2028 period and potential gross margin expansion to 83%.
Regulatory And Clinical SupportGuidelines and reimbursement changes reflect strong clinical data, with the CCTA + FFR CT pathway supported by the American Heart Association and American College of Cardiology.
Technology And InnovationHeartflow's AI-based products are set to change the standard of care in the detection of coronary artery disease.